🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessTelehealth prescribing costs — provider-by-provider breakdown

Telehealth prescribing costs — provider-by-provider breakdown

TomTeleRx Sat, Jun 6, 2026 at 11:38 AM 6 replies 244 viewsPage 1 of 2
TomTeleRx
Member
189
678
Feb 2025
Delaware
Jun 6, 2026 at 11:38 AM#1

The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from the outside.

Posting the whole record, including the parts that do not flatter my decision.

Coverage criteria are plan-specific rather than insurer-specific. Two people with the same insurer and different employers have different rules, which is why "my insurer covers it" is not transferable information.

So the question, as narrowly as I can put it: what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

46 16pete_manc_UK, anna.melb_AU, mark_tokyo and 43 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Jun 6, 2026 at 11:45 AM#2
TomTeleRx said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…
TomTeleRx said:
...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

45 15ricardo_MIA, BrianDallas92, labquiet_amy and 42 others
Reply Quote Save Share Report
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Jun 6, 2026 at 11:52 AM#3
TomTeleRx said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…

This is where I part company with the consensus forming above. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

44 14SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 41 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Jun 6, 2026 at 11:59 AM#4
DebRD_ATL said:
The affordability discussion here usually stops at individual tactics.

Insurance update relevant to cost and coverage: I just got my prior auth approved through Blue Cross after 3 attempts.

What finally worked: a letter from my endocrinologist documenting BMI history (>3 years), failed diet attempts, comorbidities (sleep apnea + prediabetes), and referencing the STEP trial data.

If your PA keeps getting denied, don't give up. Request a peer-to-peer review between your doctor and the insurance medical director. That's what finally broke through for me.

Last edited: Jun 6, 2026 at 5:59 PM
43 13jason_sac26, chris_chi24, tampaLisa73 and 40 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Jun 6, 2026 at 12:34 PM#5
CarlaRPh_TPA said:
TomTeleRx said: ...regarding the discontinuation data for cost and coverage...

Mine went the same way, slower. The detail I would add is minor and it is already implied above.

42 12DataDave, Dr.GutHealth, amsterdam_pete and 39 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register